Under CEO Richard Francis’ “Pivot to Growth” strategy, Teva Pharmaceutical Industries has undergone a significant ...

Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul.

Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...

"Detect the SOS is a multi-stakeholder movement that brings together trusted voices, advocates, healthcare professionals and ...

Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA) lawsuit against the Department of Health and Human Services (HHS) and the Department of Commerce (DOC) ...

With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...

Ro is bringing Serena Williams to the Super Bowl. Months after partnering with Williams, Ro has secured airtime at Super Bowl LX to showcase how the 23-time Grand Slam tennis champion’s life changed ...

After posting 16.2% revenue growth in the last financial year, Servier President Olivier Laureau said the company has moved ...

But while the rankings held steady, the operating environment has changed quickly to reinforce the value of being in good ...

Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

The drugmaker has recruited Will Forte, who appeared on “SNL” for nearly a decade in the aughts, perhaps most memorably as ...